Staphylococcus aureus meningitis in a patient with mantle cell lymphoma under treatment with ibrutinib

Ann Hematol. 2017 Jun;96(6):1049-1050. doi: 10.1007/s00277-017-2964-3. Epub 2017 Feb 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenine / analogs & derivatives
  • Agammaglobulinaemia Tyrosine Kinase
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Delayed Diagnosis
  • Disease Susceptibility
  • Disseminated Intravascular Coagulation / etiology
  • Fatal Outcome
  • Humans
  • Immunocompromised Host
  • Lymphoma, Mantle-Cell / complications*
  • Lymphoma, Mantle-Cell / drug therapy
  • Male
  • Meningitis, Bacterial / diagnosis
  • Meningitis, Bacterial / etiology*
  • Meningitis, Bacterial / microbiology
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / physiology
  • Piperidines
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / physiology
  • Pyrazoles / adverse effects*
  • Pyrazoles / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use
  • Receptors, Antigen, B-Cell / antagonists & inhibitors
  • Risk Factors
  • Shock, Septic / etiology

Substances

  • Antineoplastic Agents
  • Neoplasm Proteins
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • Receptors, Antigen, B-Cell
  • ibrutinib
  • Protein-Tyrosine Kinases
  • Agammaglobulinaemia Tyrosine Kinase
  • Adenine